To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure

To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure

BackgroundMineralocorticoid receptor antagonists (MRAs) are pivotal in heart failure (HF) management.ObjectivesThis study evaluates their impact on adverse cardiovascular events and left ventricular ejection fraction (LVEF) in HF patients.MethodsA comprehensive literature search was conducted across...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinyu He, Gang Chen, Yujia Huo, Chunyu Zhang, Haojie Xue, Jing Wang, Yi Zhong, Juan Xiao, Hongping Shen, Jian Feng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	heart failure mineralocorticoid receptor antagonists all-cause mortality cardiovascular death meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1564860/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mineralocorticoid receptor overactivation-induced remodeling of obese adipose tissue
by: WEN Runzhi, WANG Li, ZHAO Naiqian
Published: (2025-06-01)

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases
by: Jiao Wang, et al.
Published: (2025-08-01)

Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis
by: Chunyu Zhang, et al.
Published: (2025-06-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists
by: Biykem Bozkurt, et al.
Published: (2025-07-01)

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
by: N. A. Nuritdinov, et al.
Published: (2020-12-01)

Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk
by: F. I. Belyalov, et al.
Published: (2016-09-01)

Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study
by: Dongni Hou, et al.
Published: (2025-07-01)

Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin
by: O. A. Osipova, et al.
Published: (2021-11-01)

Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic review
by: Zeyu Chen, et al.
Published: (2023-04-01)

Endothelial Activation and Stress Index Predicts All‐Cause and Cardiovascular Mortality in Hypertensive Individuals: A Nationwide Study
by: Gaiying Dong, et al.
Published: (2025-04-01)

Association between dietary vitamin E intake and incident cardiovascular disease, cardiovascular, and all-cause mortality: A prospective cohort study using NHANES 2003–2018 data
by: Qingping Zeng, et al.
Published: (2025-03-01)

A Prospective Crossover Clinical Trial of Esaxerenone and Eplerenone in Patients with Chronic Heart Failure Complicated by Hypertension
by: Akira Sezai, et al.
Published: (2025-05-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients
by: Dragos-Florin Baba, et al.
Published: (2025-05-01)

Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice
by: Maria Alfarano, MD, PhD, et al.
Published: (2025-06-01)

Characteristics and Influencing Factors of Intra-Dialysis Blood Pressure Variability in Hemodialysis Patients: A Retrospective Study
by: Xu H, et al.
Published: (2024-10-01)

Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018
by: Zhengjin Wang, et al.
Published: (2025-05-01)

Association of frequent intradialytic hypotension with the clinical outcomes of patients on hemodialysis: a prospective cohort study
by: Yuanhao Wu, et al.
Published: (2024-12-01)

U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study
by: Yitian Dong, et al.
Published: (2025-07-01)

Metabolic syndrome and the risk of cardiovascular and all-cause mortality: data of 14-year prospective cohort study in Siberia
by: G I Simonova, et al.
Published: (2020-07-01)

Associations Between Frailty and Risk of All-Cause and Cardiovascular Mortality in Patients with Prediabetes: A Population-Based Study
by: Zhao C, et al.
Published: (2025-01-01)

Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study [Corrigendum]
by: Fei Y, et al.
Published: (2025-06-01)

Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study
by: Fei Y, et al.
Published: (2025-05-01)

Reproductive factors and risk of cardiovascular diseases and all-cause and cardiovascular mortality in American women: NHANES 2003–2018
by: Yufeng Yan, et al.
Published: (2024-04-01)

Association of glucose to lymphocyte ratio with the risk of death in patients with atherosclerotic cardiovascular disease
by: Jinglin Lei, et al.
Published: (2025-01-01)

Influencing factors of eosinophilia in peripheral blood of maintenance hemodialysis patients and its relationship with prognosis
by: Shu-min Bao, et al.
Published: (2022-08-01)

Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography
by: Qiang Li, et al.
Published: (2023-12-01)

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
by: Kisho Miyasako, et al.
Published: (2024-12-01)

Elevated Platelet‐to‐Lymphocyte Ratio as a Predictor of All‐Cause and Cardiovascular Mortality in Hypertensive Individuals
by: Rui Xu, et al.
Published: (2025-01-01)

Associations of occupation categories with cardiovascular diseases and all-cause mortality: an analysis of NHANES 2005-2014
by: Haiyang Chi, et al.
Published: (2025-05-01)

Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome
by: Qianrong Zheng, et al.
Published: (2025-04-01)

Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in hypertension: a prospective cohort study
by: Youmian Lan, et al.
Published: (2025-08-01)

Low apolipoprotein B and LDL-cholesterol are associated with the risk of cardiovascular and all-cause mortality: a prospective cohort
by: Xiaolin Yu, et al.
Published: (2025-12-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Association of hemoglobin glycation index with all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid cardiovascular disease: a population-based cohort study
by: Fachao Shi, et al.
Published: (2025-07-01)

Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
by: Houry Puzantian, et al.
Published: (2024-12-01)

U-shaped relationship between the non-HDL to HDL cholesterol ratio and mortality in hypertensive individuals in the study from NHANES database
by: Meijuan Ma, et al.
Published: (2025-07-01)

Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association
by: Mengjie Zhao, et al.
Published: (2025-01-01)